Fukutomi M, et al. - In this study with 686 ST-segment elevation myocardial infarction (STEMI) patients who underwent primary percutaneous coronary intervention (PCI), researchers assessed the outcomes in relation to stent length. They defined four groups of the participants based on total stent length: short (<18 mm, n=183), lower-medium (18–23 mm, n=256), upper-medium (24–31 mm, n=155), and long (≥32 mm, n=92). Participants were followed-up for a median duration of 1213 days, during which major adverse cardiovascular events (MACEs) and all-cause mortality were compared between these groups. Findings revealed no association between a long stent length and adverse clinical outcomes among these patients.